Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 19 May 2027
- Last conf. stmt
- 5 May 2026
Komtur Pharmaceuticals UK Limited
- Incorporated
- 23 October 2007 (19 years)
- Previously known as
- Hexagon 352 Limited (until 12 March 2008)This list may be incomplete. See all names on Companies House
- Industry
- Other human health activities (86900)
- Directors
- Joanna Kardas-AlexanderJohn Richard Newbold
- Controlled by
- Teresa Kunle
- Accounts type
- Total exemption full
- Region
- West Midlands
- Address
- Unit 2 Business Innovation CentreBinley Business ParkHarry Weston RoadCoventryCV3 2TX
Officers 2 active
Officer details are public data from the Companies House register.
Kardas-Alexander, Joanna
Director · Appointed 14 March 2025
Polish
Born December 1982 (43)
Newbold, John Richard, Mr.
Director · Appointed 5 September 2023
British
Born January 1967 (59)
Officer history (7 former)
14 March 2025
Appointed Kardas-Alexander, Joanna as Director
13 March 2025
Resigned Birkenmeier, Johannes Thomas as Director
13 March 2025
Resigned Fogelstrom, Axel as Director
5 September 2023
Appointed Newbold, John Richard, Mr. as Director
31 March 2022
Resigned Pacher-Brunninger, Alexandra, Dr as Secretary
31 March 2022
Appointed Birkenmeier, Johannes Thomas as Director
31 March 2022
Appointed Fogelstrom, Axel as Director
31 March 2022
Resigned Pacher-Brunninger, Alexandra, Dr as Director
15 January 2022
Resigned Kunle, Josef, Mr. as Director
22 January 2008
Appointed Pacher-Brunninger, Alexandra, Dr as Secretary
22 January 2008
Appointed Pacher-Brunninger, Alexandra, Dr as Director
22 January 2008
Appointed Kunle, Josef, Mr. as Director
22 January 2008
22 January 2008
23 October 2007
23 October 2007
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Teresa Kunle
Individual · Notified 15 January 2022
Has significant influence or control
German
Born August 1975 (51)
Former controllers (1)
15 January 2022
Ceased Josef Bruno Kunle — Owns 75–100% of shares
Financials
Figures from 2023 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Cash
- £722,227
- Employees
- 4
- Current Ratio
- 2.8x
Trend
Shareholder Funds
Balance sheet detail
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fixed Assets | £9,988 | £400 | £601 | £906 | £1,364 |
| Current Assets | £1,316,261 | £1,448,419 | £3,714,829 | £3,804,126 | £3,778,794 |
| Debtors | £594,034 | £1,051,938 | £3,066,181 | £2,399,386 | £3,108,506 |
| Cash | £722,227 | £393,382 | £413,898 | £1,401,737 | £620,827 |
| Creditors (< 1 year) | £467,128 | £328,415 | £2,457,201 | £2,457,420 | £2,627,639 |
| Net Current Assets | £849,133 | £1,120,004 | £1,257,628 | £1,346,706 | £1,151,155 |
| Shareholder Funds | £859,121 | £1,120,404 | £1,258,229 | £1,347,612 | £1,152,519 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 16 July 2026 | Total exemption full accounts | 31 December 2025 | ||
| 6 May 2026 | Confirmation statement with no updates | 5 May 2026 | ||
| 27 December 2025 | Total exemption full accounts | 31 December 2024 | ||
| 11 June 2025 | Confirmation statement with no updates | 13 May 2025 | ||
| 14 March 2025 | Termination of appointment of a director |
Other companies in this industry
Birmingham
Peterborough
Malvern
London
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →